Ultra-high dose rate (FLASH) radiotherapy has been attracting world-wide interest since it was re-discovered in 2014. FLASH appears to spare normal tissue while still suppressing tumour growth. If FLASH fulfils its potential it could deliver a paradigm change in radiotherapy. 

This meeting is to provide a national forum for FLASH research and to look at the pipeline from basic research to the clinic. It is suitable for those who are already involved in the field and those who want to find out more.